Pharma Journalist -

Bora Pharmaceuticals and South Korea-based Onconic Therapeutics have entered into a manufacturing agreement to support the U.S. clinical development of JAQBO, an investigational…
Read More...

Lundbeck has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Lu AH69593, its investigational oral orexin 2 receptor agonist being developed to treat…
Read More...

Affinia Therapeutics has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for its investigational gene therapy AFTX-201, marking another regulatory…
Read More...

BeOne Medicines has announced a $300 million investment to expand its flagship manufacturing and research facility in Hopewell, New Jersey, strengthening its U.S. production…
Read More...

Kairos Pharma has announced a strategic collaboration with Bayer to evaluate a new combination treatment approach for metastatic castration-resistant prostate cancer (mCRPC) that has…
Read More...

Cellares and Papillon Therapeutics have announced a strategic collaboration to automate the manufacturing of PPL-001, an investigational gene-edited cell therapy being developed to…
Read More...

GSK has received U.S. Food and Drug Administration (FDA) approval for Jideytro (zidesamtinib), a next-generation targeted therapy for adults with locally advanced or metastatic…
Read More...

Crystalys Therapeutics has secured $130 million in an oversubscribed Series B financing round to support the late-stage clinical development and commercialization of its lead gout…
Read More...

Evogene Ltd. and South Korea-based biotechnology company ELEO Inc. have entered into a strategic scientific collaboration to develop next-generation oral small-molecule therapies…
Read More...

Lonza and Engitix have entered into a licensing agreement aimed at accelerating the development of next-generation antibody-drug conjugates (ADCs), combining Lonza’s established drug…
Read More...